Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mahesh Pattabiraman
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults aged 19 years and older experiencing chronic neuropathic pain that is refractory to medical treatment and eligible for SCS based on FDA-approved indications.
Individuals who can legally provide informed consent.
You may not be if
Patients unable or unwilling to adhere to the requirements of remote monitoring, follow-up schedules, or other aspects of the study protocol.
Patients with uncontrolled psychiatric conditions, including severe depression or anxiety, which could interfere with their ability to participate fully in the study or accurately report outcomes.
Women who are currently pregnant or breastfeeding, as the safety and efficacy of SCS in these populations are not established.
Patients who have previously experienced significant adverse events or complications from SCS implantation or stimulation that would make further use unsafe or ineffective.
Patients with other active implantable devices (e.g., pacemakers or defibrillators) that could interfere with the functionality of the SCS system.
Patients with a documented history of substance abuse within